Furthermore, a recent study showed that low concentrations of galectin-1 can induce chondrogenic differentiation of mesenchymal stem cells (MSCs) from RA bone marrow [80], suggesting a potential application of galectin-1 in cartilage transplantation treatment for RA. The gene discussed is LGALS1; the disease is rheumatoid arthritis.